CTCFL and cancer: BORIS prevents cancer cells from undergoing apoptosis and protects genomic stability, as shown in our previous studies [17, 24, 28]; hence, BTApep-TAT treatment may attenuate the protective effect of BORIS on cancer cell genome stability.